ClinicalTrialsFinder

CDK12 Gene Mutation Clinical Trials in Tianjin, Tianjin Municipality

1 recruitingTianjin, Tianjin Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure

Prostate CancerCDK12 Gene Mutation
Tianjin Medical University Second Hospital72 enrolled1 locationNCT06663007